|
|
||||||||
Ann Thorac Surg 2007;83:424
© 2007 The Society of Thoracic Surgeons
Department of Thoracic Surgery, Vanderbilt University, 2971 The Vanderbilt Clinic, 1301 22nd Ave S, Nashville, TN 37232-5734
(Email: bill.putnam@vanderbilt.edu).
| The first 20% of the full text of this article appears below. |
The authors [1] examined the role of serum carcinoembryonic antigen (CEA) level as a prognostic factor in patients with nonsmall cell lung cancer (NSCLC). Small studies have examined this serum marker; however CEA has not yet reached the level of evidence necessary for incorporation into consensus conference guidelines for staging or prognosis. Still, studies from Japan [2, 3] and the
Related Article
Ann. Thorac. Surg. 2007 83: 419-424.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |